Angiotensin II upregulates vascular CaV1.2 protein expression by stimulating endothelial NAD(P)H oxidase-produced H2O2.
No immediate clinical implications; hypothesis-generating for endothelial ROS in vascular signaling and requires human validation.
Background: We previously reported that angiotensin II caused an endothelial-dependent increase in L-type voltage-dependent Ca²⁺ channel (CaV1.2) in cultured arteries, but the signaling pathways are not clear. Methods: Endothelial damage was generated by brief intra-arterial perfusion with 0.3% CHAPS. CaV1.2 expression, function and H₂O₂ were measured by Western blot, tension recording and Amplex Red H₂O₂ assay kit, respectively. Results: Angiotensin II dose-dependently upregulated CaV1.2 expression in endothelium-intact arteries. The angiotensin II upregulation of CaV1.2 expression in endothelium-intact arteries was blocked by NAD(P)H oxidase inhibitor diphenyleneiodonium (DPI), apocynin, a more specific NAD(P)H oxidase inhibitor gp91ds-tat and also by catalase. H₂O₂ similarly upregulated CaV1.2 expression in endothelium-intact and endothelium-damaged arteries, and the latter effect was also blocked by DPI and apocynin. Angiotensin II increased H₂O₂ production by endothelium-intact but not by endothelium-damaged arteries, and this effect was blocked by apocynin, catalase and gp91ds-tat. The upregulation of CaV1.2 by angiotensin II and H₂O₂ is accompanied by an increased tension response to KCl and the Ca²⁺ channel activator FPL 64176, and this effect was also attenuated by gp91ds-tat. Conclusion: These results suggest that angiotensin II stimulates endothelial NAD(P)H oxidase-produced H₂O₂, which may additionally act through vascular smooth muscle NAD(P)H oxidase, to upregulate vascular CaV1.2 protein.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: